Skip to main content
Clinical Trials/JPRN-UMIN000011319
JPRN-UMIN000011319
Completed
未知

Examination of ocular blood flow and reduction of intraocular pressure, comparing Tafuluprost and Tafuruprost Bunazosin with primary open angle Glaucoma. - Examination of ocular blood flow and reduction of intraocular pressure, comparing Tafuluprost and Tafuruprost Bunazosin with primary open angle Glaucoma.

Department of Ophthalmology, Kanazawa University0 sites12 target enrollmentJuly 30, 2013
ConditionsGlaucoma

Overview

Phase
未知
Intervention
Not specified
Conditions
Glaucoma
Sponsor
Department of Ophthalmology, Kanazawa University
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Instillation of tafluprost significantly reduced intraocular pressure, but there was no change in microcirculation of optic disc.

Registry
who.int
Start Date
July 30, 2013
End Date
November 4, 2009
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Ophthalmology, Kanazawa University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who have ocular diseases without glaucoma and mild cataract(diabates retinopathy or morbid myopia or etc) 2\) Progressive or severe glaucoma(for example using a Humphery field analyzer,MD \<\-12dB,0dB detection is in 5degree) 3\) Patients with any corneal abnormality or other condition preventing reliable applanation tonometry. 4\) Patients with anamnestic hitory of hypersensitivity to prostagrandin analogs and benzalkonium chloride. 5\) Patients with active external ocular diseases,ocular inflammation or infection. 6\) Patients with history of reflactive surgery. 7\) Patients with history of internal ocular surgery within 6month before the study (cataract surgery,SLT,trabecrctomy,trabecrotomy etc). 8\) Smoker 9\) Patients who are unable to undergo ocular blood flow test. 10\) Pregnant,lactating women ,the women who desired of the pregnancy during the test period. 11\) Patients who are going to use prohibited drugs during test period. 12\) Doctor judged to be inelible to the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials